Journal article icon

Journal article : Review

Cardiovascular mortality and depression: A systematic review and meta-analysis of the association with antidepressant treatment and co-morbidity

Abstract:
Background: Depression is associated with increased mortality, with underlying causes unclear. We conducted a systematic review and meta-analysis of cardiovascular (CV) mortality in depression and how antidepressant treatments and comorbidities modify this. Methods: We searched Medline, Embase, Scopus, Web of Science and Cochrane registers (inception to 31 December 2024) for randomised controlled trials (RCTs) and observational studies comparing CV mortality in adults with depression vs without, and receiving antidepressants vs controls. We excluded studies with <12 months follow-up, reporting only all-cause mortality or lacking control groups. Random-effects meta-analyses were conducted with CV mortality as the primary outcome. Risk of bias was assessed with RoB 2 and ROBINS-I. PROSPERO: CRD42020200812. Results: We included 7 RCTs and 47 cohort studies (1,593,722 people). In multivariable-adjusted cohorts (k = 26), depression was associated with a significantly higher CV mortality versus no-depression (hazard ratio (HR): 1.45, 95% CI: 1.25–1.69). Effects were similar in non-selected community-dwelling cohorts and those with CV disease or type 2 diabetes. Antidepressants overall were associated with increased CV mortality in cohorts but after adjustment only tricyclic antidepressants (TCAs) had significantly increased risk vs no antidepressant (k = 4; HR: 1.27, 95% CI: 1.02–1.58). RCT findings were directionally consistent but underpowered. Conclusions: Depression is associated with increased risk of CV mortality irrespective of comorbid group studied. Antidepressants do not appear to modify this risk, apart from TCAs, which may increase it. The antidepressant models in particular had high heterogeneity, reflecting a knowledge gap on the long-term effects of antidepressants in patients with depression on CV mortality.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1177/02698811261433212

Authors

More by this author
Role:
Author
ORCID:
0000-0002-3666-7531
More by this author
Role:
Author
ORCID:
0000-0002-5812-3121
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Experimental Psychology
Sub department:
Experimental Psychology
Role:
Author
ORCID:
0009-0006-3106-1502
More by this author
Role:
Author
ORCID:
0009-0005-0073-0614


More from this funder
Funder identifier:
https://doi.org/10.13039/501100012295
Grant:
NIHR203309


Publisher:
SAGE Publications
Journal:
Journal of Psychopharmacology More from this journal
Volume:
40
Issue:
4
Pages:
486-508
Publication date:
2026-05-07
DOI:
EISSN:
1461-7285
ISSN:
0269-8811


Language:
English
Keywords:
Subtype:
Review
Source identifiers:
4247341
Deposit date:
2026-06-19
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP